Sarepta Therapeutics
SRPT
#1687
Rank
โ‚น873.05 B
Marketcap
โ‚น8,998
Share price
-2.40%
Change (1 day)
-10.57%
Change (1 year)
Sarepta Therapeutics is an American medical research company dedicated to the discovery and development of precisely effective gene therapeutics for the treatment of rare neuromuscular diseases.

Sarepta Therapeutics (SRPT) - Total debt

Total debt on the balance sheet as of December 2024 : โ‚น117.29 Billion

According to Sarepta Therapeutics 's latest financial reports the company's total debt is โ‚น117.29 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Sarepta Therapeutics - Total debt on balance sheet (from 2007 to 2024)

Total debt by year

Year Total debt Change
2024-12-31โ‚น115.21 B-0.92%
2023-12-31โ‚น116.28 B-13.12%
2022-12-31โ‚น133.83 B55.89%
2021-12-31โ‚น85.85 B9.42%
2020-12-31โ‚น78.46 B50.8%
2019-12-31โ‚น52.02 B76.94%
2018-12-31โ‚น29.40 B6.84%
2017-12-31โ‚น27.52 B2407.85%
2016-12-31โ‚น1.09 B-29.42%
2015-12-31โ‚น1.55 B287.71%
2014-12-31โ‚น0.40 B289.19%
2013-12-31โ‚น0.10 B7.12%
2012-12-31โ‚น96.2 M-1.27%
2011-12-31โ‚น97.44 M13.08%
2010-12-31โ‚น86.16 M-7.19%
2009-12-31โ‚น92.84 M-25.42%
2008-12-31โ‚น0.12 B48.1%
2007-12-31โ‚น84.05 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
โ‚น2.332 T 1,888.80%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น20.12 B-82.84%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น0.59 B-99.49%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น70.62 B-39.78%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น113.18 B-3.50%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น215.79 B 83.99%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น100.33 B-14.46%๐Ÿ‡บ๐Ÿ‡ธ USA